A review of monoclonal antibody therapies in lymphoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference140 articles.
1. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies;Alduaij;Blood,2011
2. Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia;Badoux;Blood,2011
3. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation;Barrena;Leukemia,2005
4. CD20 as a target for therapeutic type I and II monoclonal antibodies;Beers;Semin. Hematol.,2010
5. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-hodgkin’s lymphoma;Berinstein;Ann. Oncol.: Offf. J. Euro. Soc. Med. Oncol./ESMO,1998
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Electrochemical Investigations of Protein Denaturating Agents Dithiobutylamine and Dithiothreitol and of the Antineoplastic Alemtuzumab at Glassy Carbon Electrode;Journal of the Brazilian Chemical Society;2024
2. Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling;International Journal of Molecular Sciences;2023-03-15
3. Monoclonal Antibody and Targeted Toxin Therapy;Holland‐Frei Cancer Medicine;2022-10-21
4. A Novel Anti-CD22 scFv.Bim Fusion Protein Effectively Induces Apoptosis in Malignant B cells and Promotes Cytotoxicity;Applied Biochemistry and Biotechnology;2022-07-15
5. Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens;Frontiers in Immunology;2022-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3